Published in Cancer Epidemiol on January 03, 2013
Rapid learning in practice: a lung cancer survival decision support system in routine patient care data. Radiother Oncol (2014) 0.86
A Bayesian Approach to Account for Misclassification and Overdispersion in Count Data. Int J Environ Res Public Health (2015) 0.77
Using expert opinion to quantify unmeasured confounding bias parameters. Can J Public Health (2016) 0.75
The validity of self-reported smoking: a review and meta-analysis. Am J Public Health (1994) 13.69
A method to automate probabilistic sensitivity analyses of misclassified binary variables. Int J Epidemiol (2005) 5.17
Bayesian perspectives for epidemiological research: I. Foundations and basic methods. Int J Epidemiol (2006) 3.03
Effect of breast cancer radiotherapy and cigarette smoking on risk of second primary lung cancer. J Clin Oncol (2008) 1.83
Bayesian perspectives for epidemiological research. II. Regression analysis. Int J Epidemiol (2007) 1.56
Use of serum cotinine to assess the accuracy of self reported non-smoking. Br Med J (Clin Res Ed) (1986) 1.36
Sensitivity analysis of misclassification: a graphical and a Bayesian approach. Ann Epidemiol (2006) 1.30
Bayesian perspectives for epidemiologic research: III. Bias analysis via missing-data methods. Int J Epidemiol (2009) 1.22
Ionizing radiation and tobacco use increases the risk of a subsequent lung carcinoma in women with breast cancer: case-only design. J Clin Oncol (2005) 1.22
Lung cancer risks in women with previous breast cancer. Eur J Cancer (2002) 1.19
Bayesian methods for correcting misclassification: an example from birth defects epidemiology. Epidemiology (2009) 1.19
A sensitivity analysis using information about measured confounders yielded improved uncertainty assessments for unmeasured confounding. J Clin Epidemiol (2007) 1.11
Assessing the convergence of Markov Chain Monte Carlo methods: an example from evaluation of diagnostic tests in absence of a gold standard. Prev Vet Med (2007) 1.07
Effects of smoking and radiotherapy on lung carcinoma in breast carcinoma survivors. Cancer (2003) 1.06
Case-control analysis with partial knowledge of exposure misclassification probabilities. Biometrics (2001) 1.05
Smoking imputation and lung cancer in railroad workers exposed to diesel exhaust. Am J Ind Med (2006) 0.94
Hierarchical priors for bias parameters in Bayesian sensitivity analysis for unmeasured confounding. Stat Med (2012) 0.89
The effects of radiotherapy for the treatment of contralateral breast cancer. Breast Cancer Res Treat (2006) 0.82
Pathological confirmation of primary lung cancer following breast cancer. Lung Cancer (2009) 0.82
Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet (2009) 7.62
Genetic variation and cancer: improving the environment for publication of association studies. Cancer Epidemiol Biomarkers Prev (2004) 6.24
Novel nicotine delivery systems and public health: the rise of the "e-cigarette". Am J Public Health (2010) 4.21
Epidemiology of primary brain tumors: current concepts and review of the literature. Neuro Oncol (2002) 3.99
Projecting individualized absolute invasive breast cancer risk in African American women. J Natl Cancer Inst (2007) 3.93
Reduced nicotine content cigarettes: effects on toxicant exposure, dependence and cessation. Addiction (2010) 3.26
A road map for efficient and reliable human genome epidemiology. Nat Genet (2006) 3.21
Residual risk of breast cancer recurrence 5 years after adjuvant therapy. J Natl Cancer Inst (2008) 3.17
Circulating tumor cells: a useful predictor of treatment efficacy in metastatic breast cancer. J Clin Oncol (2009) 2.52
Nicotine metabolite ratio predicts efficacy of transdermal nicotine for smoking cessation. Clin Pharmacol Ther (2006) 2.49
Inflammatory breast cancer: the disease, the biology, the treatment. CA Cancer J Clin (2010) 2.45
Cancer survivorship--genetic susceptibility and second primary cancers: research strategies and recommendations. J Natl Cancer Inst (2006) 2.42
Relationship between obesity and pathologic response to neoadjuvant chemotherapy among women with operable breast cancer. J Clin Oncol (2008) 2.40
Mitochondrial DNA content: its genetic heritability and association with renal cell carcinoma. J Natl Cancer Inst (2008) 2.17
Pancreatic cancer genetic epidemiology consortium. Cancer Epidemiol Biomarkers Prev (2006) 2.04
Cigarette smoking, N-acetyltransferase 2 genotypes, and breast cancer risk: pooled analysis and meta-analysis. Cancer Epidemiol Biomarkers Prev (2008) 1.97
Genome-wide association study of glioma and meta-analysis. Hum Genet (2012) 1.96
Breast cancer risk in premenopausal women is inversely associated with consumption of broccoli, a source of isothiocyanates, but is not modified by GST genotype. J Nutr (2004) 1.90
Chromosome 7p11.2 (EGFR) variation influences glioma risk. Hum Mol Genet (2011) 1.83
The role of CYP2A6 in the emergence of nicotine dependence in adolescents. Pediatrics (2006) 1.83
Reconciling human smoking behavior and machine smoking patterns: implications for understanding smoking behavior and the impact on laboratory studies. Cancer Epidemiol Biomarkers Prev (2009) 1.82
Modeling the impact of treatment and screening on U.S. breast cancer mortality: a Bayesian approach. J Natl Cancer Inst Monogr (2006) 1.73
The etiology of alcohol-induced breast cancer. Alcohol (2005) 1.73
Smoking, alcoholism and genetic polymorphisms alter CYP2B6 levels in human brain. Neuropharmacology (2003) 1.70
The emergence of networks in human genome epidemiology: challenges and opportunities. Epidemiology (2007) 1.61
Folate pathway polymorphisms predict deficits in attention and processing speed after childhood leukemia therapy. Pediatr Blood Cancer (2011) 1.55
Interacting effects of genetic predisposition and depression on adolescent smoking progression. Am J Psychiatry (2004) 1.50
Elafin is downregulated during breast and ovarian tumorigenesis but its residual expression predicts recurrence. Breast Cancer Res (2014) 1.46
GLIOGENE an International Consortium to Understand Familial Glioma. Cancer Epidemiol Biomarkers Prev (2007) 1.42
Polymorphisms of LIG4, BTBD2, HMGA2, and RTEL1 genes involved in the double-strand break repair pathway predict glioblastoma survival. J Clin Oncol (2010) 1.40
Relation between food reinforcement and dopamine genotypes and its effect on food intake in smokers. Am J Clin Nutr (2004) 1.34
Effects of dopamine transporter and receptor polymorphisms on smoking cessation in a bupropion clinical trial. Health Psychol (2003) 1.32
Bleomycin-induced chromosome breaks as a risk marker for lung cancer: a case-control study with population and hospital controls. Carcinogenesis (2003) 1.31
Evaluation of in vitro assays for assessing the toxicity of cigarette smoke and smokeless tobacco. Cancer Epidemiol Biomarkers Prev (2009) 1.30
Clinical trials methods for evaluation of potential reduced exposure products. Cancer Epidemiol Biomarkers Prev (2009) 1.29
High quality copy number and genotype data from FFPE samples using Molecular Inversion Probe (MIP) microarrays. BMC Med Genomics (2009) 1.29
Glutathione S-transferase polymorphisms and survival in primary malignant glioma. Clin Cancer Res (2004) 1.27
Pharmacogenetic clinical trial of sustained-release bupropion for smoking cessation. Nicotine Tob Res (2007) 1.26
Cruciferous vegetables, genetic polymorphisms in glutathione S-transferases M1 and T1, and prostate cancer risk. Nutr Cancer (2004) 1.24
Surveillance methods for identifying, characterizing, and monitoring tobacco products: potential reduced exposure products as an example. Cancer Epidemiol Biomarkers Prev (2009) 1.24
Ionizing radiation and tobacco use increases the risk of a subsequent lung carcinoma in women with breast cancer: case-only design. J Clin Oncol (2005) 1.22
Bupropion efficacy for smoking cessation is influenced by the DRD2 Taq1A polymorphism: analysis of pooled data from two clinical trials. Nicotine Tob Res (2007) 1.21
A comprehensive study of the association between the EGFR and ERBB2 genes and glioma risk. Acta Oncol (2010) 1.17
Mutagen sensitivity has high heritability: evidence from a twin study. Cancer Res (2006) 1.16
Genetic advances in glioma: susceptibility genes and networks. Curr Opin Genet Dev (2010) 1.14
Assessing consumer responses to potential reduced-exposure tobacco products: a review of tobacco industry and independent research methods. Cancer Epidemiol Biomarkers Prev (2009) 1.13
Pharmacogenetic investigation of smoking cessation treatment. Pharmacogenetics (2002) 1.13
Associations between cigarette smoking and mitochondrial DNA abnormalities in buccal cells. Carcinogenesis (2008) 1.13
CT quality assurance in the lung screening study component of the National Lung Screening Trial: implications for multicenter imaging trials. AJR Am J Roentgenol (2009) 1.12
Effect of team sport participation on genetic predisposition to adolescent smoking progression. Arch Gen Psychiatry (2006) 1.12
A Ser49Cys variant in the ataxia telangiectasia, mutated, gene that is more common in patients with breast carcinoma compared with population controls. Cancer (2004) 1.11
Association of catechol-O-methyltransferase with smoking cessation in two independent studies of women. Pharmacogenet Genomics (2005) 1.11
MDM2 SNP309 and SNP354 are not associated with lung cancer risk. Cancer Epidemiol Biomarkers Prev (2006) 1.10
DNA hypermethylation and clinicopathological features in breast cancer: the Western New York Exposures and Breast Cancer (WEB) Study. Breast Cancer Res Treat (2008) 1.10
Can the blind see? Participant guess about treatment arm assignment may influence outcome in a clinical trial of bupropion for smoking cessation. J Subst Abuse Treat (2007) 1.08
Deciphering the 8q24.21 association for glioma. Hum Mol Genet (2013) 1.08
A multi-center population-based case-control study of ovarian cancer in African-American women: the African American Cancer Epidemiology Study (AACES). BMC Cancer (2014) 1.08
Non-steroidal anti-inflammatory drugs (NSAIDs) and breast cancer risk: differences by molecular subtype. Cancer Causes Control (2011) 1.06
Mutagen sensitivity and genetic variants in nucleotide excision repair pathway: genotype-phenotype correlation. Cancer Epidemiol Biomarkers Prev (2007) 1.05
Common genetic variation in TP53 is associated with lung cancer risk and prognosis in African Americans and somatic mutations in lung tumors. Cancer Epidemiol Biomarkers Prev (2007) 1.05
Lung cancer survival and functional polymorphisms in MBL2, an innate-immunity gene. J Natl Cancer Inst (2007) 1.05
Less efficient g2-m checkpoint is associated with an increased risk of lung cancer in African Americans. Cancer Res (2005) 1.05
Skilled use of DNA polymorphisms as a tool for polygenic cancers. Carcinogenesis (2002) 1.04
Childhood exposure to secondhand smoke and functional mannose binding lectin polymorphisms are associated with increased lung cancer risk. Cancer Epidemiol Biomarkers Prev (2009) 1.04
Chromosome 9 arm-specific telomere length and breast cancer risk. Carcinogenesis (2009) 1.03
p53 Mutation analysis in breast tumors by a DNA microarray method. Cancer Epidemiol Biomarkers Prev (2006) 1.02
Reproductive factors, heterogeneity, and breast tumor subtypes in women of mexican descent. Cancer Epidemiol Biomarkers Prev (2013) 1.02
Non-steroidal anti-inflammatory drug (NSAID) use and breast cancer risk in the Western New York Exposures and Breast Cancer (WEB) Study. Cancer Causes Control (2010) 1.01
The molecular epidemiology of gliomas in adults. Neurosurg Focus (2005) 1.01
Food mutagens. J Nutr (2003) 1.00
Tobacco and cancer: an American Association for Cancer Research policy statement. Cancer Res (2010) 0.99
CYP2B6 genotype does not alter nicotine metabolism, plasma levels, or abstinence with nicotine replacement therapy. Cancer Epidemiol Biomarkers Prev (2007) 0.98
Lack of association of 5-HTTLPR genotype with smoking cessation in a nicotine replacement therapy randomized trial. Cancer Epidemiol Biomarkers Prev (2006) 0.98
Changes in food reward following smoking cessation: a pharmacogenetic investigation. Psychopharmacology (Berl) (2004) 0.97
Accurate genotyping from paraffin-embedded normal tissue adjacent to breast cancer. Carcinogenesis (2005) 0.97
Single-nucleotide polymorphisms in DNA repair genes and association with breast cancer risk in the web study. Carcinogenesis (2011) 0.97
Accounting for response misclassification and covariate measurement error improves power and reduces bias in epidemiologic studies. Ann Epidemiol (2010) 0.96
Reduced allergy and immunoglobulin E among adults with intracranial meningioma compared to controls. Int J Cancer (2011) 0.96
Effect modification by catalase genotype suggests a role for oxidative stress in the association of hormone replacement therapy with postmenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev (2008) 0.95
Vitamin D receptor gene polymorphisms are associated with adiposity phenotypes. Am J Clin Nutr (2010) 0.95
Risk analysis of severe myelotoxicity with temozolomide: the effects of clinical and genetic factors. Neuro Oncol (2009) 0.94
Polymorphisms in XPD and TP53 and mutation in human lung cancer. Carcinogenesis (2004) 0.94
Use of nonsteroidal anti-inflammatory drugs and survival following breast cancer diagnosis. Cancer Epidemiol Biomarkers Prev (2011) 0.94
Metabolic polymorphisms, smoking, and oral cancer in Puerto Rico. Oncol Res (2004) 0.94
Adipokines in plasma and breast tissues: associations with breast cancer risk factors. Cancer Epidemiol Biomarkers Prev (2012) 0.93
Cigarette filter-based assays as proxies for toxicant exposure and smoking behavior--a literature review. Cancer Epidemiol Biomarkers Prev (2009) 0.92
Mortality among capacitor workers exposed to polychlorinated biphenyls (PCBs), a long-term update. Int Arch Occup Environ Health (2014) 0.92
Alcohol consumption and genetic variation in methylenetetrahydrofolate reductase and 5-methyltetrahydrofolate-homocysteine methyltransferase in relation to breast cancer risk. Cancer Epidemiol Biomarkers Prev (2009) 0.91
Exposures associated with serum organochlorine levels among postmenopausal women from western New York State. Am J Ind Med (2002) 0.91
Changes in body mass index and alcohol and tobacco consumption among breast cancer survivors and cancer-free women: a prospective study in the Danish Diet, Cancer and Health Cohort. Acta Oncol (2012) 0.90
Comparison of birth weight corrected for gestational age and birth weight alone in prediction of development of childhood leukemia and central nervous system tumors. Pediatr Blood Cancer (2010) 0.90
Elevated lung cancer risk is associated with deficiencies in cell cycle checkpoints: genotype and phenotype analyses from a case-control study. Int J Cancer (2010) 0.90
DNA promoter methylation in breast tumors: no association with genetic polymorphisms in MTHFR and MTR. Cancer Epidemiol Biomarkers Prev (2009) 0.90
New NCCN Guidelines: Smoking Cessation for Patients With Cancer. J Natl Compr Canc Netw (2015) 0.90
Alcohol consumption in relation to aberrant DNA methylation in breast tumors. Alcohol (2010) 0.90
Association of metabolic gene polymorphisms with tobacco consumption in healthy controls. Int J Cancer (2004) 0.89
Quantitative immunohistochemical analysis and prognostic significance of TRPS-1, a new GATA transcription factor family member, in breast cancer. Horm Cancer (2010) 0.89
Telomere deficiencies on chromosomes 9p, 15p, 15q and Xp: potential biomarkers for breast cancer risk. Hum Mol Genet (2010) 0.88
Leveraging ethnic group incidence variation to investigate genetic susceptibility to glioma: a novel candidate SNP approach. Front Genet (2012) 0.88
Re: Commonly studied single-nucleotide polymorphisms and breast cancer: results from the Breast Cancer Association Consortium. J Natl Cancer Inst (2007) 0.88